CCF Webinar: A trial of next generation immunotherapy (Rilvegostomig) plus chemotherapy in advanced biliary tract cancer (ARTEMIDE-Biliary02) June 16 @ 4:00 pm - 5:00 pm Supported by AstraZeneca